Department of Pediatric Surgery, Faculty of Medicine, Ataturk University, 25240, Erzurum, Turkey.
Surg Today. 2012 Nov;42(11):1051-60. doi: 10.1007/s00595-011-0074-8. Epub 2011 Dec 28.
To investigate the effects of metyrosine, lacidipine, clonidine, and moxonidine on the renal damage in rats with unilateral ureteral ligation by examining the histological evidence of parenchymal damage and tubular dilatation, as well as biochemical changes indicating cell membrane damage and DNA oxidation.
Thirty-six albino Wistar rats were randomly divided into six equal groups: a healthy (intact) group, a unilateral ureteral ligation (control) group, and four drug treatment groups given metyrosine (50 mg/kg), lacidipine (2 mg/kg), clonidine (0.075 mg/kg), or moxonidine (0.2 mg/kg), respectively, for 10 days. The latter five groups underwent ligation of the left ureter. Ten days after the operation, we removed both kidneys from each rat in the control and drug treatment groups for renal pathological and biochemical [malondialdehyde (MDA), total glutathione, 8-hydroxy-2-deoxyguanine (8-OH-Gua)] examinations. Spectrophotometric assays were used to detect the malondialdehyde and total glutathione levels of the renal tissue. High-performance liquid chromatography was used to measure the 8-hydroxy-2-deoxyguanine levels.
When the drug treatment groups were compared with the control group, the drug treatment groups' total glutathione level was higher and their malondialdehyde level was lower than that of the control group (P < 0.05), especially in the clonidine group (P < 0.0001). The 8-hydroxy-2-deoxyguanine levels of the drug treatment groups, except the lacidipine group, were significantly lower than that of the control group (P < 0.0001). There was no significant difference between the contralateral kidneys of the treatment groups and control group, according to the biochemical results. As revealed via light microscopy, clonidine and moxonidine treatment significantly reduced the tubular and glomerular damage, as well as the tubular dilation. The interstitial inflammation of the kidneys in the lacidipine group was higher than that of the other treatment groups. However, the apoptotic cell count was at a high level in both the lacidipine and metyrosine groups. The increase in the collagen content was most pronounced in the lacidipine and metyrosine groups. An examination of the contralateral kidneys showed no marked pathological findings.
The use of a direct or indirect α2-adrenergic receptor agonist for the temporary treatment of unilateral ureteral obstruction-induced renal damage may be important for preventing renal structural injury. A more advanced study is necessary to determine the mechanisms underlying the protective effects of these drugs with regard to renal damage in ureteral obstruction.
通过观察肾实质损伤和管状扩张的组织学证据,以及表明细胞膜损伤和 DNA 氧化的生化变化,研究甲酪氨酸、拉西地平、可乐定和莫索尼定对单侧输尿管结扎大鼠肾脏损伤的影响。
36 只白化 Wistar 大鼠随机分为 6 组,每组 6 只:健康(完整)组、单侧输尿管结扎(对照)组和 4 个药物治疗组,分别给予甲酪氨酸(50mg/kg)、拉西地平(2mg/kg)、可乐定(0.075mg/kg)或莫索尼定(0.2mg/kg),共 10 天。后 5 组进行左侧输尿管结扎。手术后 10 天,从对照组和药物治疗组的每只大鼠中取出双侧肾脏,进行肾脏病理和生化[丙二醛(MDA)、总谷胱甘肽、8-羟基-2-脱氧鸟苷(8-OH-Gua)]检查。分光光度法检测肾组织 MDA 和总谷胱甘肽水平。高效液相色谱法用于测量 8-羟基-2-脱氧鸟苷水平。
与对照组相比,药物治疗组的总谷胱甘肽水平升高,丙二醛水平降低(P<0.05),尤其是可乐定组(P<0.0001)。除拉西地平组外,药物治疗组的 8-羟基-2-脱氧鸟苷水平均明显低于对照组(P<0.0001)。根据生化结果,治疗组对侧肾脏与对照组无明显差异。光镜下,可乐定和莫索尼定治疗可显著减轻肾小管和肾小球损伤及肾小管扩张。拉西地平组肾脏间质炎症高于其他治疗组。然而,拉西地平组和甲酪氨酸组的凋亡细胞计数较高。胶原含量增加最明显的是拉西地平组和甲酪氨酸组。对侧肾脏检查未见明显病理发现。
使用直接或间接α2-肾上腺素能受体激动剂临时治疗单侧输尿管梗阻引起的肾损伤,可能对预防肾结构损伤很重要。需要进一步研究这些药物对输尿管梗阻肾损伤的保护作用的机制。